Park Avenue Securities LLC Has $5.20 Million Position in Stryker Corporation $SYK

Park Avenue Securities LLC boosted its holdings in shares of Stryker Corporation (NYSE:SYK) by 12.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,066 shares of the medical technology company’s stock after buying an additional 1,539 shares during the period. Park Avenue Securities LLC’s holdings in Stryker were worth $5,200,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in SYK. Mid American Wealth Advisory Group Inc. acquired a new stake in shares of Stryker in the 2nd quarter worth about $26,000. Clayton Financial Group LLC bought a new stake in Stryker during the 3rd quarter worth approximately $26,000. Elevation Point Wealth Partners LLC purchased a new stake in shares of Stryker in the second quarter worth approximately $28,000. Sachetta LLC lifted its holdings in shares of Stryker by 58.7% in the second quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 27 shares in the last quarter. Finally, Kilter Group LLC purchased a new position in shares of Stryker during the second quarter valued at approximately $29,000. 77.09% of the stock is owned by institutional investors.

Stryker Price Performance

Shares of NYSE:SYK opened at $367.13 on Friday. The company has a market capitalization of $140.40 billion, a P/E ratio of 48.24, a price-to-earnings-growth ratio of 2.36 and a beta of 0.89. The company’s 50-day moving average is $359.67 and its 200 day moving average is $375.24. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.13 and a current ratio of 1.85. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Friday, October 31st. The medical technology company reported $3.19 EPS for the quarter, topping the consensus estimate of $3.13 by $0.06. The business had revenue of $6.06 billion for the quarter, compared to analyst estimates of $6.04 billion. Stryker had a net margin of 12.07% and a return on equity of 24.07%. The company’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.87 earnings per share. On average, equities research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be paid a $0.88 dividend. The ex-dividend date is Wednesday, December 31st. This is a positive change from Stryker’s previous quarterly dividend of $0.84. This represents a $3.52 annualized dividend and a yield of 1.0%. Stryker’s dividend payout ratio (DPR) is currently 46.25%.

Wall Street Analysts Forecast Growth

SYK has been the subject of a number of analyst reports. Weiss Ratings reissued a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. Citizens Jmp upgraded shares of Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 target price for the company in a research note on Friday, December 19th. Rothschild Redb raised shares of Stryker to a “hold” rating in a research report on Thursday, September 18th. Raymond James Financial upgraded shares of Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price target on the stock in a report on Tuesday. Finally, Wells Fargo & Company increased their price objective on shares of Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a research note on Friday, November 14th. Fourteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $430.40.

Insider Activity at Stryker

In other news, CAO William E. Berry, Jr. sold 1,953 shares of the company’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $365.49, for a total transaction of $713,801.97. Following the transaction, the chief accounting officer owned 2,833 shares of the company’s stock, valued at $1,035,433.17. This represents a 40.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronda E. Stryker sold 276,173 shares of the stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $353.28, for a total value of $97,566,397.44. Following the transaction, the director owned 2,702,108 shares of the company’s stock, valued at $954,600,714.24. The trade was a 9.27% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 522,118 shares of company stock worth $185,381,932. Insiders own 5.90% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.